Literature DB >> 11120330

Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization.

X Y Guan1, S B Fu, J C Xia, Y Fang, J S Sham, B D Du, H Zhou, S Lu, B Q Wang, Y Z Lin, Q Liang, X M Li, B Du, X M Ning, J R Du, P Li, J M Trent.   

Abstract

Comparative genomic hybridization (CGH) has been applied to detect recurrent chromosome alterations in 62 primary gastric carcinomas. Several nonrandom chromosomal changes, including gains of 8q (31 cases, 50%), 20q (29 cases, 47%) with a minimum gain region at 20q11. 2-q12, 13q (21 cases, 34%) with a minimum gain region at 13q22, and 3q (19 cases, 31%) were commonly observed. The regions most frequently lost included: 19p (23 cases, 37%), 17p (21 cases, 33%), and 1p (14 cases, 23%). High copy number gain (DNA sequence amplification) was detected in 6 cases. Amplification of 8q23-q24.2 and 20q11.2-q12 were observed in 3 cases. Gain of 20q and loss of 19p were confirmed by fluorescence in situ hybridization using corresponding bacterial artificial chromosomes (BAC) clones from those regions. The gain and loss of chromosomal regions identified in this study provide candidate regions involved in gastric tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120330     DOI: 10.1016/s0165-4608(00)00306-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

1.  Overexpression of EIF5A2 is associated with poor survival and aggressive tumor biology in gallbladder cancer.

Authors:  Xin Zheng; Lei Gao; Bo-Tao Wang; Ping Shen; Xiang-Fei Yuan; Lan-Qiu Zhang; Lei Yang; Da-Peng Zhang; Qi Zhang; Xi-Mo Wang
Journal:  Histol Histopathol       Date:  2019-11-20       Impact factor: 2.303

2.  NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines.

Authors:  Tineke E Buffart; Marianne Tijssen; Jamila El-Bchiri; Alex Duval; Mark A van de Wiel; Bauke Ylstra; Gerrit A Meijer; Beatriz Carvalho
Journal:  BMC Med Genomics       Date:  2009-06-29       Impact factor: 3.063

3.  Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?

Authors:  Takahisa Nakayama; Zhi-Qiang Ling; Ken-ichi Mukaisho; Takanori Hattori; Hiroyuki Sugihara
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

4.  Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas.

Authors:  Yuan-Yuan Liu; Hai-Ying Chen; Man-Li Zhang; Dan Tian; Shibo Li; Ji-Yun Lee
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

5.  Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer.

Authors:  B G Schneider; S Y Rha; H C Chung; J C Bravo; R Mera; J C Torres; K T Plaisance; R Schlegel; C M McBride; X T Reveles; R J Leach
Journal:  Mol Pathol       Date:  2003-06

6.  Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma.

Authors:  Felix H Shek; Sarwat Fatima; Nikki P Lee
Journal:  Int J Hepatol       Date:  2012-09-18

7.  Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection.

Authors:  Hark Kyun Kim; Joseph Kim; Susie Korolevich; Il Ju Choi; Chang Hee Kim; David J Munroe; Jeffrey E Green
Journal:  BMC Med Genomics       Date:  2011-06-02       Impact factor: 3.063

8.  Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer.

Authors:  Qing-Bin Meng; Wei-Ming Kang; Jian-Chun Yu; Yu-Qin Liu; Zhi-Qiang Ma; Li Zhou; Quan-Cai Cui; Wei-Xun Zhou
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 9.  Roles of eukaryotic initiation factor 5A2 in human cancer.

Authors:  Feng-wei Wang; Xin-yuan Guan; Dan Xie
Journal:  Int J Biol Sci       Date:  2013-10-12       Impact factor: 6.580

10.  RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition.

Authors:  María Fernanda Rubio; María Cecilia Lira; Francisco Damián Rosa; Adrían Dario Sambresqui; María Cecilia Salazar Güemes; Mónica Alejandra Costas
Journal:  Cancer Cell Int       Date:  2017-11-28       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.